After much confusion, especially with the Sinovac vaccine results, The Brazilian National Health Surveillance Agency (Anvisa) approved the emergency use […]
Local public health agencies in Brazil continue to offer community and ambulatory-based access to COVID-19 treatments not approved or accepted […]
ANVISA, Brazil’s drug regulatory, halted the Sinovac Phase 3 clinical trial testing the Chinese company’s COVID-19 vaccine after a volunteer […]
In early September, the AstraZeneca/Oxford vaccine trials were put on temporary hold across all international testing sites due to a […]
The Russian vaccine known as “Sputnik V,” developed by the Gamaleya National Research Institute of Epidemiology and Microbiology, was registered […]
Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s […]
An Old Drug Tackles New Tricks: Ivermectin Treatment in Three Brazilian Towns: TrialSite News continues to develop a global network […]
TrialSite News continues to develop a global network of individuals, from all walks of life, participating and sharing their experiences […]
Brazilian billionaire Jorge Lemann’s foundation and other ventures will inject the needed capital into the manufacture of a production factory to […]
Recently, the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária) known as ANVISA shared an updated technical note, offering […]
